Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NDA to be submitted in Japan for nevirapine

May 27, 1997

Antiretroviral therapy and hearing loss

May 23, 1997

HIV-1 RT inhibitors from Boehringer Ingelheim

May 20, 1997

Steroidogenesis Inhibitors initiates phase I/II trial of HIV treatment

May 20, 1997

MPL vaccine adjuvant offered for licensing by Ribi

May 19, 1997

Roche seeks FDA approval for new formulation of saquinavir

May 14, 1997

Gilead Sciences initiates phase I/II trial of oral PMPA for HIV treatment

May 14, 1997

Menarini prepares new NNRTIs with potent anti-HIV activity

May 13, 1997

LeukoSite and collaborators discover monoclonal antibody that blocks HIV infection

May 13, 1997

Update on Interferon Sciences' Alferon N Injection

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...